TC-1698

TC-1698 is a drug developed by Targacept which acts as a partial agonist for the α7 subtype of neural nicotinic acetylcholine receptors.^[1] It has neuroprotective effects in animal studies,^[2] and has been used as a lead compound to find further potent derivatives.^[3]

TC-1698

Legal status
Legal status	In general: legal
Identifiers
IUPAC name 2-pyridin-3-yl-1-azabicyclo[3.2.2]nonane
CAS Number	700834-58-8
PubChem CID	10130417
ChemSpider	8305933 N
UNII	NF9LS47A5E
ChEMBL	ChEMBL2151442 N
CompTox Dashboard (EPA)	DTXSID40435998
Chemical and physical data
Formula	C13H18N2
Molar mass	202.301 g·mol−1
3D model (JSmol)	Interactive image
SMILES c2ncccc2C1CCC3CCN1CC3
InChI InChI=1S/C13H18N2/c1-2-12(10-14-7-1)13-4-3-11-5-8-15(13)9-6-11/h1-2,7,10-11,13H,3-6,8-9H2 N Key:WIEWCOLOPGXZDJ-UHFFFAOYSA-N N
NY (what is this?)  (verify)

See also

• Anabasine
• Epibatidine